Tanya Siddiqi

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma”.

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL

Blood Cancer Discovery(2023)10.1158/2643-3230.bcd-22-0156

N/A

0.903DataRank · unranked

29 citations

Meiling Jin, Mike M. Fernandez, Kevyn L. Hart, Aijun Liao, Xinzhou Ge +16 more

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

Journal of Clinical Oncology(2021)10.1200/jco.21.00807

N/A

0.816DataRank · unranked

229 citations

John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Stephen Opat, Alessandra Tedeschi +16 more

Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials

Blood Advances(2024)10.1182/bloodadvances.2023011307

N/A

0.442DataRank · unranked

18 citations

Jeff P. Sharman, Paolo Ghia, Jennifer A. Woyach, Toby A. Eyre, Wojciech Jurczak +7 more

International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations

Blood(2025)10.1182/blood.2024028064

N/A

0.425DataRank · unranked

16 citations

Monia Marchetti, Othman Al‐Sawaf, Ohad Benjamini, Alexey V. Danilov, Matthew S. Davids +24 more

Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7552

N/A

0.396DataRank · unranked

13 citations

Frederick L. Locke, Zhen‐Huan Hu, Tanya Siddiqi, Sairah Ahmed, Armin Ghobadi +15 more

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology(2024)10.1002/ajh.27283

N/A

0.241DataRank · unranked

4 citations

Hailin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson +18 more

Relapse after First-Line Fixed Duration Ibrutinib + Venetoclax: High Response Rates to Ibrutinib Retreatment and Absence of BTK Mutations in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) with up to 5 Years of Follow-up in the Phase 2 Captivate Study

Blood(2023)10.1182/blood-2023-187128

N/A

0DataRank · unranked

39 citations

William G. Wierda, Paul M. Barr, Thomas J. Kipps, Tanya Siddiqi, John N. Allan +6 more

MGA deletion leads to Richter’s transformation via modulation of mitochondrial OXPHOS

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.07.527502

N/A

0DataRank · unranked

2 citations

Bo Zhang, Tingting Liu, Meiling Jin, Kevyn L. Hart, Jibin Zhang +7 more

Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

(2023)10.1158/2326-6066.c.6550309

N/A

0DataRank · unranked

0 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

(2023)10.1158/2326-6066.c.6550309.v1

N/A

0DataRank · unranked

0 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

Undetectable MRD Status in Patients with R/R CLL/SLL with Stable Disease after Lisocabtagene Maraleucel Treatment: Exploratory Analysis of the TRANSCEND CLL 004 Study

Blood(2023)10.1182/blood-2023-180230

N/A

0DataRank · unranked

0 citations

Sahar Ansari, Jason Wall, Ethan Thompson, Yizhe Chen, Tanya Siddiqi +6 more

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Blood(2023)10.1182/blood-2023-173992

N/A

0DataRank · unranked

0 citations

Ted Gooley, Tanya Siddiqi, Deborah M. Stephens, Catherine M. Broome, Stephen E. Spurgeon +18 more

MGA deletion leads to Richter’s transformation by modulating mitochondrial OXPHOS

Science Translational Medicine(2024)10.1126/scitranslmed.adg7915

N/A

0DataRank · unranked

11 citations

Bo Zhang, Tingting Liu, Meiling Jin, Kevyn L. Hart, Jibin Zhang +14 more

Trends in First-Line Use of Radiation Therapy for Early-Stage Gastric Marginal Zone Lymphoma

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.07.1471

N/A

0DataRank · unranked

0 citations

Amanda Schwer, Savita Dandapani, J.Y.C. Wong, Nayel Khan, Avyakta Kallam +11 more

233 | S1608: RANDOMIZED PHASE II TRIAL COMPARING LENALIDOMIDE/OBINUTUZUMAB AND UMBRALISIB/OBINUTUZUMAB WITH CHEMOIMMUNOTHERAPY IN EARLY PROGRESSING FOLLICULAR LYMPHOMA (POD24)

Hematological Oncology(2025)10.1002/hon.70094_233

N/A

0DataRank · unranked

0 citations

H. Li, Heiko Schöder, Alex F. Herrera, Richard Burack, Brian K. Link +10 more

The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Cancer Immunology Research(2020)10.1158/2326-6066.cir-20-0236

N/A

0DataRank · unranked

46 citations

Christian Huynh, Ryan Urak, Lihong Weng, Miriam Walter, Laura Lim +21 more

Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.4787

N/A

0DataRank · unranked

16 citations

Vincent Chung, Joseph M. Tuscano, Tanya Siddiqi, Sagus Sampath, Jeff Longmate +3 more

Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer

Molecular Cell(2021)10.1016/j.molcel.2021.03.043

N/A

0DataRank · unranked

30 citations

M. Martin, Kohei Kume, Mark E. Robinson, Supraja Saravanakumar, Gal Lenz +25 more

Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.017

N/A

0DataRank · unranked

7 citations

Joycelynne Palmer, Timothy W. Synold, Behrouz Salehian, Michael Rosenzweig, James F. Sanchez +12 more

Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7100

N/A

0DataRank · unranked

12 citations

Aleksi Iukuridze, Tianhui He, Alysia Bosworth, Lanie Lindenfeld, Jennifer Berano Teh +17 more